Annual CAPEX
$2.46 M
+$1.22 M+98.55%
December 31, 2023
Summary
- As of February 8, 2025, KROS annual capital expenditures is $2.46 million, with the most recent change of +$1.22 million (+98.55%) on December 31, 2023.
- During the last 3 years, KROS annual CAPEX has risen by +$2.17 million (+738.10%).
- KROS annual CAPEX is now at all-time high.
Performance
KROS CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$386.00 K
+$76.00 K+24.52%
September 30, 2024
Summary
- As of February 8, 2025, KROS quarterly capital expenditures is $386.00 thousand, with the most recent change of +$76.00 thousand (+24.52%) on September 30, 2024.
- Over the past year, KROS quarterly CAPEX has dropped by -$155.00 thousand (-28.65%).
- KROS quarterly CAPEX is now -63.65% below its all-time high of $1.06 million, reached on March 31, 2023.
Performance
KROS Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$2.18 M
-$164.00 K-6.99%
September 30, 2024
Summary
- As of February 8, 2025, KROS TTM capital expenditures is $2.18 million, with the most recent change of -$164.00 thousand (-6.99%) on September 30, 2024.
- Over the past year, KROS TTM CAPEX has dropped by -$281.00 thousand (-11.40%).
- KROS TTM CAPEX is now -11.40% below its all-time high of $2.46 million, reached on December 31, 2023.
Performance
KROS TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
KROS CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +98.5% | -28.6% | -11.4% |
| 3 y3 years | +738.1% | +166.2% | +136.0% |
| 5 y5 years | +1035.5% | +370.7% | +705.5% |
KROS CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +140.6% | -63.6% | +162.6% | -11.4% | +127.2% |
| 5 y | 5-year | at high | +809.2% | -63.6% | +2044.4% | -11.4% | +766.3% |
| alltime | all time | at high | +1035.5% | -63.6% | +2044.4% | -11.4% | +1176.6% |
Keros Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $386.00 K(+24.5%) | $2.18 M(-7.0%) |
| Jun 2024 | - | $310.00 K(-67.2%) | $2.35 M(-0.0%) |
| Mar 2024 | - | $946.00 K(+74.9%) | $2.35 M(-4.7%) |
| Dec 2023 | $2.46 M(+98.5%) | $541.00 K(-1.6%) | $2.46 M(+8.4%) |
| Sep 2023 | - | $550.00 K(+76.8%) | $2.27 M(+19.7%) |
| Jun 2023 | - | $311.00 K(-70.7%) | $1.90 M(-11.9%) |
| Mar 2023 | - | $1.06 M(+202.6%) | $2.16 M(+73.7%) |
| Dec 2022 | $1.24 M(+21.2%) | $351.00 K(+99.4%) | $1.24 M(+18.3%) |
| Sep 2022 | - | $176.00 K(-69.0%) | $1.05 M(+3.0%) |
| Jun 2022 | - | $567.00 K(+285.7%) | $1.02 M(+5.9%) |
| Mar 2022 | - | $147.00 K(-7.5%) | $961.00 K(-6.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $1.02 M(+248.3%) | $159.00 K(+9.7%) | $1.02 M(+10.7%) |
| Sep 2021 | - | $145.00 K(-71.6%) | $925.00 K(+14.2%) |
| Jun 2021 | - | $510.00 K(+142.9%) | $810.00 K(+147.0%) |
| Mar 2021 | - | $210.00 K(+250.0%) | $328.00 K(+11.6%) |
| Dec 2020 | $294.00 K(+8.5%) | $60.00 K(+100.0%) | $294.00 K(+16.7%) |
| Sep 2020 | - | $30.00 K(+7.1%) | $252.00 K(-17.1%) |
| Jun 2020 | - | $28.00 K(-84.1%) | $304.00 K(-32.0%) |
| Mar 2020 | - | $176.00 K(+877.8%) | $447.00 K(+64.9%) |
| Dec 2019 | $271.00 K(+24.9%) | $18.00 K(-78.0%) | $271.00 K(+7.1%) |
| Sep 2019 | - | $82.00 K(-52.0%) | $253.00 K(+48.0%) |
| Jun 2019 | - | $171.00 K | $171.00 K |
| Dec 2018 | $217.00 K | - | - |
FAQ
- What is Keros Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Keros Therapeutics?
- What is Keros Therapeutics annual CAPEX year-on-year change?
- What is Keros Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Keros Therapeutics?
- What is Keros Therapeutics quarterly CAPEX year-on-year change?
- What is Keros Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Keros Therapeutics?
- What is Keros Therapeutics TTM CAPEX year-on-year change?
What is Keros Therapeutics annual capital expenditures?
The current annual CAPEX of KROS is $2.46 M
What is the all time high annual CAPEX for Keros Therapeutics?
Keros Therapeutics all-time high annual capital expenditures is $2.46 M
What is Keros Therapeutics annual CAPEX year-on-year change?
Over the past year, KROS annual capital expenditures has changed by +$1.22 M (+98.55%)
What is Keros Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of KROS is $386.00 K
What is the all time high quarterly CAPEX for Keros Therapeutics?
Keros Therapeutics all-time high quarterly capital expenditures is $1.06 M
What is Keros Therapeutics quarterly CAPEX year-on-year change?
Over the past year, KROS quarterly capital expenditures has changed by -$155.00 K (-28.65%)
What is Keros Therapeutics TTM capital expenditures?
The current TTM CAPEX of KROS is $2.18 M
What is the all time high TTM CAPEX for Keros Therapeutics?
Keros Therapeutics all-time high TTM capital expenditures is $2.46 M
What is Keros Therapeutics TTM CAPEX year-on-year change?
Over the past year, KROS TTM capital expenditures has changed by -$281.00 K (-11.40%)